Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

A novel 1p36.2 located ge… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Artikel i vetenskaplig tidskrift
Författare Cecilia Krona
Katarina Ejeskär
Helena Carén
Frida Abel
Rose-Marie Sjöberg
Tommy Martinsson
Publicerad i British journal of cancer
Volym 91
Nummer/häfte 6
Sidor 1119-30
ISSN 0007-0920
Publiceringsår 2004
Publicerad vid Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik
Sidor 1119-30
Språk en
Länkar dx.doi.org/10.1038/sj.bjc.6602083
Ämnesord Amino Acid Sequence, Animals, Apoptosis Regulatory Proteins, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 1, genetics, DNA Primers, Genes, Tumor Suppressor, Humans, Molecular Sequence Data, Mutation, genetics, Neuroblastoma, genetics, Polymerase Chain Reaction, Promoter Regions (Genetics), genetics, RNA, Messenger, genetics, Sequence Alignment, Sequence Homology, Amino Acid, Tumor Suppressor Protein p53, genetics, Tumor Suppressor Proteins, genetics
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Neuroblastoma is characterised by a lack of TP53 mutations and no other tumour suppressor gene consistently inactivated has yet been identified in this childhood cancer form. Characterisation of a new gene, denoted APITD1, in the neuroblastoma tumour suppressor candidate region in chromosome 1p36.22 reveals that APITD1 contains a predicted TFIID-31 domain, representing the TATA box-binding protein-associated factor, TAF(II)31, which is required for p53-mediated transcription activation. Two different transcripts of this gene were shown to be ubiquitously expressed, one of them with an elevated expression in foetal tissues. Primary neuroblastoma tumours of all different stages showed either very weak or no measurable APITD1 expression, contrary to the level of expression observed in neuroblastoma cell lines. A reduced pattern of expression was also observed in a set of various tumour types. APITD1 was functionally tested by adding APITD1 mRNA to neuroblastoma cells, leading to the cell growth to be reduced up to 90% compared to control cells, suggesting APITD1 to have a role in a cell death pathway. Furthermore, we determined the genomic organisation of APITD1. Automated genomic DNA sequencing of the coding region of the gene as well as the promoter sequence in 44 neuroblastoma tumours did not reveal any loss-of-function mutations, indicating that mutations in APITD1 is not a common abnormality of neuroblastoma tumours. We suggest that low expression of this gene might interfere with the ability for apoptosis through the p53 pathway.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?